AG (Switzerland).
Solid-Phase Synthesis of Histidine Oligopeptides The histidine oligopeptides, (His) i Gly (iϭ9, 19, 29) , and their acetyl derivatives, Ac-(His) i Gly (iϭ9, 19) , were synthesized by a solid-phase technique on an semi-automatic peptide synthesizer LKB BIOLYNX 4175 (Bromma, Sweden) using Ultrosyn resin. Firstly, Fmoc-His(Boc)-OPFP was coupled to the glycine attached on Ultrosyn resin by HOBT to yield Fmoc-His(Boc)-Glyresin. Next, the Fmoc at the amino terminus of Fmoc-His(Boc)-Gly-resin was removed with a 20% piperidine in DMF to yield His(Boc)-Gly-resin, which was subsequently coupled to Fmoc-His(Boc)-OPFP affording the Fmoc-His(Boc)-His(Boc)-Gly-resin. The same procedure was repeated until the appropriate Fmoc-[His(Boc)] i -Gly-resin was synthesized. Finally, the Fmoc group at the amino terminus of the Fmoc-[His(Boc)] i -Gly-resin was removed by a 20% piperidine in DMF to yield [His(Boc)] i -Gly-resin. Cleavage and deprotection of the peptide from the resin were achieved by treatment with 95% TFA for 1 h at room temperature. The N-acetyl derivatives of [His(Boc)] i -Gly were prepared by treatment with 10% acetic anhydride in DMF. The synthesized histidine oligopeptide mixtures were separated and purified by high performance liquid chromatography on the TSKgel SP-2SW column (Tosoh Co., Japan) according to the method described previously. 18) Liquid-Phase Synthesis of Histidine Oligopeptides (His) 4 Gly was synthesized by a conventional liquid-phase method. Starting materials were Boc-His(MBS)-OH and Gly-OBzl p-TsOH, and DEPC was used as a coupling agent. Firstly, Boc-His(MBS)-Gly-OBzl was prepared and subsequently treated with 50% TFA for 50 min affording NH 2 -His(MBS)-GlyOBzl. This was then coupled with Boc-His(MBS)-OH to yield Boc-[His(MBS)] 2 -Gly-OBzl. Finally, Boc-[His(MBS)] 4 -Gly-OBzl prepared by stepwise coupling was treated with hydrogen fluoride (HF) in the presence of anisole to afford (His) 4 Gly. Stepwise procedures are summarized in Chart 1. The peptide was purified according to the method described previously.
18)
Procedure for the Measurement of Ascorbate Autoxidation Routinely, the reactions were carried out at 25°C and pH 4.4 under dioxygen.
Solutions of 8.0ϫ10
Ϫ5 mol dm Ϫ3 ascorbate and 4.0ϫ10 Ϫ6 mol dm Ϫ3 Cu(II) complexes, which were prepared freshly before kinetic runs in 0.02 mol dm Ϫ3 acetate buffer, were mixed with a UNION MX-7 rapid-mixing apparatus to start the reaction, and subsequent changes in absorbance at 260 nm were monitored on a UNION SM-401 spectrophotometer. Before and during the measurement, the solutions were purged with water-saturated O 2 at 100 ml/min. The activity, v obsd , was obtained from the initial rate of ascorbate consumption. The dead-time of the mixing apparatus was assessed within 1 s.
Circular Dichroism (CD) Measurement Measurements of CD were carried out at room temperature and pH 4.4 in 0.02 mol dm Ϫ3 acetate buffer, and the concentration of Cu(II) was fixed at 8.1ϫ10
Ϫ5 mol dm Ϫ3 . The spectrum was recorded from 300 nm to 700 nm on a JASCO J-40 spectropolarimeter. Cell length used here was 5 cm.
Analysis of Kinetic Data The oxidation of ascorbate obeys the "Michaelis-Menten" mechanism and the rate, v obsd , is expressed by Eq. 1; 15) 
where [AscH] 0 stands for the total concentration of ascorbate. The terms, v max and K m , are the maximum rate and the "Michaelis-Menten" constant given by Eqs. 2 and 3, respecitvely; 
Results and Discussion
Catalytic Activities Both (His) i Gly and Ac-(His) i Gly (iϭ9, 19) accelerated the copper-catalyzed autoxidation of ascorbic acid. The rate-pH plots showed bell-shaped curves with a maximum around pH 4.4. Subsequently, spectroscopic and kinetic experiments were done at pH 4.4. The systems without Cu(II) lack the catalytic activity.
(1) Coppers Associated with (His) i Gly: Plots of the relative rate, v/v 0 , against the concentrations of (His) i Gly (iϭ1, 4, 9, 19, 29) are shown in Fig. 1 , and [(His) i Gly] is varied. The rate depended not only on the concentration but also the molecular weight of the peptides. The Cu(II) complexed with HisGly did not affect the oxidation; the rate was approximately the same as that of aqueous Cu(II). In the pH range from 4 to 5, HisGly forms CuL or CuL 2 species with a histamine-like coordination structure, where L represents the peptide. 19) This suggests that Cu(II) with histamine-like coordination structures neither accelerates nor inhibits the autoxidation. Under optimum conditions, the Cu(II) complexed with (His) 4 Gly enhanced the reaction approximately 1.2-fold, but the Cu(II) with (His) 9 Gly increased the rate 2.5-fold. Thus, the molecular weight of the peptide, i.e., numbers of serial histidyl residues, contributes to the enhancement of the catalytic activity. When the v/v 0 values exhibited maxima, the peptide would bind enough Cu(II) ions to work efficiently. In terms of maximum v/v 0 , the various (His) i Gly complexes ranked in increasing order as follows; (2) Coppers Associated with Ac-(His) i Gly: Ac-(His) i Gly lacks the binding site at the amino terminus. Their complexes were catalytically more active than the corresponding (His) i Gly complexes. In Fig. 2 increased, the activity resulted in a rapid drop probably because the active Cu(II) sites on the peptide would be dispersed. However, the Ac-(His) i Gly, lacking the Cu(II) site at the amino terminus, did not make the v/v 0 drop below unity. Thus, blocking of the teminal binding site certainly induced enhancement of the reaction system. The v/v 0 for Ac-(His) i Gly complexes was arranged as follows;
Ac-(His) 9 Gly (2)ϽAc-(His) 19 Gly (3) where in parentheses are shown (number of Hisresidue)/[Cu(II)]. The (His) i Gly could accommodate more than one molar Cu(II), as compared with the corresponding N-acetylated peptides. This is probably due to the Cu(II) bound at the amino terminus. Enhancement of the activities by N-acetylation is as follows:
Ac-(His) 9 Gly/(His) 9 Glyϭ1.4 and Ac-(His) 19 Gly/(His) 19 Glyϭ1.2 Though the increase in the autoxidation rate is related to the increase in the total number of His-residues, the enhancement by N-acetylation is not. In other words, the contribution of the inhibitory Cu(II) to the reaction is diminished with the increase in total His-numbers.
Coordination Modes and Structures of the Cu(II) Complexes Circular dichroism has been shown to provide useful information about environments around metal sites. 20) Coordination of a transition metal ion with a chiral ligand induces the CD at its d-d transition band, and the l max depends on the ligand-field strength. 21) In an attempt to obtain information on the Cu(II) binding sites, measurements of the CD spectra of Cu(II) with (His) i Gly (iϭ9, 19, 29) and Ac-(His) i Gly (iϭ9, 19) were made.
(1) Cu(II) Complexes of (His)iGly: The CD spectra of the Cu(II) with (His) 19 Gly at various [L]/[Cu(II)] 0 ratios from 0.06 to 1.9 are shown in Fig. 3 19 Gly; (᭝-᭝): Ac-(His) 9 Gly; (᭺-᭺): Ac-(His) 19 Gly. Conditions are the same as in Fig. 1 . Data are the average of at least three experiments. /Cu(II)): 520 nm (0.68) and 630 nm (Ϫ0.36) for Ac-(His) 9 Gly complex, 520 nm (0.47) and 630 nm (Ϫ0.09) for Ac-(His) 19 Gly complex. The De for the Ac-(His) 9 Gly complex is bigger than that of the Ac-(His) 19 Gly, probably because of steric strain around the Cu(II) sites. Those N-acetylated peptides lacking the binding-site at the amino terminal could incorporate Cu(II) in the imidazole cluster to a limit. Thus, the 520/630 nm bands are assignable to the Cu(II) accommodated in the imidazole cluster, and the 480/550 nm bands to that at the amino terminus. The titration curves for Ac-(His) 19 Gly and (His) 19 Gly are shown in Figs. 5A and 5B. The maximum binding numbers for Ac-(His) 9 Gly and Ac-(His) 19 Gly were calculated as approximately 2 and 3 mol, respectively. The maximum u for (His) 19 Gly and for (His) 29 Gly are difficult to determine. Since these peptides possess two types of Cu(II) ions having different l max , the titration curve appeared complicated and inter- Mechanism of the Ascorbate Oxidation The autoxidation of ascorbic acid by the poly-L-histidine (degree of polymerizationϭca. 50) complexes has been shown to obey the "Michaelis-Menten" mechanism and can be expressed briefly by Eqs. 4 and 5. where L, Asc Ϫ and Asc · represent ligands, ascorbate, and its free radical, respectively. Double reciprocal plots of the rate against the concentration of the substrates give straight lines. When ascorbate was arranged as the variable substrate and dioxygen as the changing fixed substrate, the family of lines in a reciprocal plot was parallel. 15) This fits the "Ping-Pong" mechanism. 22) Oxidation by the (His) i Gly and Ac-(His) i Gly complexes appeared a little complicated. In the system with low molecular-weight peptides, such as HisGly and probably (His) 4 Gly, the family of lines in a reciprocal plot intersect at a point. This fits the "sequential mechanism". 7, 22) Spectroscopic studies have revealed that both (His) i Gly and Ac-(His) i Gly complexes accommodate multi-equivalent Cu(II) ions. The autoxidation by those Cu(II) complexes occurs primarily by the "Ping-Pong" mechanism. Double reciprocal plots for the systems containing (His) 19 Gly and Ac-(His) 19 Gly at an appropriate [L]/[Cu(II)] 0 ratio are shown in Figs. 6A and 6B. However, since the peptide is capable of accommodating different [Ac(His) 19 The autoxidation can be expressed as a composite reactions (4-a), (4-b), ···, and (4-i). The plots for Ac-(His) 19 Gly were always expressed by a single saturation curve with K m ϭ2.5Ϫ3.5ϫ10 Ϫ5 mol dm
Number of Cu(II) Ions Bound to the Peptides
[ [ Cu(I)]-L O H Cu(II)]-L H O 3 ϩ ϩ ϩ ϩ Ϫ 2 2 2 2 3 k k → ← [ [ [ Cu(II)] L Asc L Cu(II)]Asc Cu(I)] L Asc - - ϩ ٞ ϩ Ϫ Ϫ k 1 Ϫ k k 1 2 ⋅ → → ←
Ϫ3
and v m ϭ2.6Ϫ3.3ϫ10 Ϫ5 mol dm
/min, indicating that the reactions obey the "Michaelis-Menten" mechanism.
Conclusion
The catalytic activities of Cu(II) toward the autoxidation of ascorbic acid were enhanced more than two-fold by the complexation with histidine oligopeptide. Not only the molecular weight of the peptide but also the number of serial histidyl residues affects the enhancement. This is supported by the observation that addition of a large excess of Ac-His-NHCH 3 19 does not accelerate the autoxidation.
17) The Cu(II) coordinated with the amino terminal peptide fragment; i.e., NH 2 -X-Y-His-(X and Y denote amino acid residues), certainly inhibits the reaction. The imidazole cluster constructed with the sequence of -(His) n -is necessary for the Cu(II) complex to have high catalytic activity. The minimum number of histidyl residues is five or six. These peptides are likely to coordinate with two Cu(II) ions or more which exhibit two CD bands at 520 and 630 nm and are readily dissociable from the complexes by the addition of NaClO 4 or CH 3 COONa. 15) The involvement of free metal ions in in vivo oxidation has been questioned because most of these ions are linked to prosthetic groups or are tightly sequestered by specific binding proteins. Experiments with autoxidation by the labile Cu(II) bound to Ac-(His) i Gly suggest the presence of a labile and catalytically active metal in the metalloprotein. Labile Cu(II) bound to an imidazole group, which is Chelex-removable, has been found in ceruloplasmin, and has catalytic activity inducing oxidation of low density lipoprotein. 
